Developing and Validating Fertilit-e



Status:Recruiting
Healthy:No
Age Range:18 - 39
Updated:2/17/2019
Start Date:August 15, 2018
End Date:August 2019
Contact:Denisha Little-Greene
Email:drlittle@wakehealth.edu
Phone:336-713-5061

Use our guide to learn which trials are right for you!

Developing and Validating Fertilit-e: An eHealth Fertility Preservation Decision Aid for Young Adults With Cancer - Aim 1

The main purpose of this project is to adapt and validate an eHealth fertility preservation
decision-making support tool (Fertilit-e) for young adults with cancer.

The overarching goal is to utilize innovations in eHealth technology to address fertility
preservation knowledge deficits and decision-making options for young adults with cancer ages
18-39 years of age. Every year, approximately 70,000 young adults (ages 18-39) are diagnosed
with cancer, which can significantly affect their health-related quality of life in multiple
areas, including the potential for infertility or other reproductive challenges. Despite
this, very few young adults diagnosed with cancer are actually provided fertility
preservation information let alone effective strategies or tools for how to best navigate
their fertility preservation options. It is critical to provide decision-making information
and support about infertility risk and existing interventions to maintain reproductive
potential in a delivery mode that is most congruent with this population's health
communication style, such as eHealth applications.

The goal is to adapt and optimize fertility preservation content in a tailored mHealth tool
for fertility preservation decision-making. More specifically, the team will adapt
fertility-preservation content for tailored, rapid, and clear dissemination of information in
an engaging, cross-platform, patient-friendly mHealth format. The study team will alpha-test
this tool with an ethnically diverse sample of cross-cultural end users to collect
qualitative data and evaluate usability and comprehensibility to refine content and design.
No formal hypothesis testing will be done.

Inclusion Criteria:

- Histologically confirmed diagnosis of cancer during ages 15 to 39.

- Will be receiving or have received treatment associated with a risk of infertility
(i.e., systemic chemotherapy, pelvic radiotherapy, and/or pelvic surgery with
potential impact on reproductive function).

- Considered or wish they had considered fertility preservation treatments.

- Able to speak, read, and understand English.

- Able to provide informed consent.

Exclusion Criteria:

- Infertility diagnosis prior to cancer diagnosis.

- History of fertility preservation or fertility treatments prior to their cancer
diagnosis.

- Are more than two years post-cancer-related treatments (i.e., systemic chemotherapy,
pelvic radiotherapy, and/or pelvic surgery).
We found this trial at
1
site
Winston-Salem, North Carolina 27157
Phone: 336-713-5061
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials